SelectQuote, Inc. (NYSE:SLQT) President Robert Clay Grant bought 79,801 shares of the company's common stock on November 6, 2026, according to a recent insider transaction disclosure. The shares were acquired at prices ranging from $0.415 to $0.53, inclusive, for a total transaction value of $40,299. The weighted average purchase price came to $0.505 per share.
The open-market purchase arrives with SelectQuote's stock quoted at $0.46, a level that reflects a decline of more than 71% over the past year. An analysis of the company's valuation indicates the shares appear undervalued at current prices, with a Fair Value estimate of $0.61. SelectQuote is also included on a list of Most Undervalued stocks.
After the transaction, Mr. Grant directly holds 3,386,491 shares of SelectQuote common stock. Beyond his direct position, he beneficially owns shares through several entities and trusts. These indirect holdings include 1,242,000 shares held by Mr. Grant as Trustee for the Robert Clay Grant Irrevocable Trust. Another 1,089,369 shares are beneficially owned through Haakon Capital, LLC, an investment company in which Mr. Grant holds a one-third ownership stake. He disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.
In addition, 101,421 shares are held by the R. Grant Irrevocable Trust, 100,914 shares by the G. Grant Irrevocable Trust, and 100,766 shares by the A. Grant Irrevocable Trust. All three trusts are held indirectly by Mr. Grant in his capacity as Trustee for the benefit of his minor children.
The insider purchase coincides with a period in which SelectQuote has reported financial results for the first quarter of fiscal 2027. The company posted an adjusted loss of $0.21 per share, which was narrower than the analyst expectation of a negative $0.34 per share. Revenue, however, came in below forecasts at $280 million, compared with an anticipated $326.17 million.
SelectQuote emphasized improvements in adjusted EBITDA, which showed a $15 million year-over-year enhancement, reaching a loss of $17 million. The trailing 12-month adjusted EBITDA increased by 30% from the previous year to $124 million. The company maintained its fiscal 2027 operating cash flow guidance of at least $60 million.
According to the company, the revenue decline was attributed to a smaller agent force in the Senior business and reduced Healthcare Services revenue due to the Inflation Reduction Act. SelectQuote continues to focus on AI, automation, and a reduced agent force to maintain its margins.
The disclosed transaction provides a view into insider activity at the company, though it represents a single purchase and does not, by itself, indicate a broader trend. The purchase price range and weighted average offer context for the level at which the shares were acquired relative to the current market price. The direct and indirect holdings disclosed after the transaction outline the president's total beneficial ownership structure.
Investors tracking SelectQuote will weigh the insider purchase alongside the company's recent quarterly performance, including the revenue shortfall and the factors cited for the decline, as well as the maintained cash flow guidance and the emphasis on operational efficiency measures.